445
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Interleukin 8 and hepatocyte growth factor in predicting development of severe acute pancreatitis

, , , , , , , , , , ORCID Icon & | (Reviewing Editor) show all
Article: 1396634 | Received 23 Jul 2017, Accepted 19 Oct 2017, Published online: 03 Nov 2017

References

  • Aoun, E., Chen, J., Reighard, D., Gleeson, F. C., Whitcomb, D. C., & Papachristou, G. I. (2009). Diagnostic accuracy of interleukin-6 and interleukin-8 in predicting severe acute pancreatitis: A meta-analysis. Pancreatology, 9, 777–785.10.1159/000214191
  • Banks, P. A., Bollen, T. L., Dervenis, C., Gooszen, H. G., Johnson, C. D., Sarr, M. G., … Vege, S. S. (2013). Classification of acute pancreatitis–2012: Revision of the Atlanta classification and definitions by international consensus. Gut, 62, 102–111.10.1136/gutjnl-2012-302779
  • Beger, H. G., Bittner, R., Block, S., & Buchler, M. (1986). Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology, 91, 433–438.
  • Bollen, T. L., Singh, V. K., Maurer, R., Repas, K., Van Es, H. W., Banks, P. A., & Mortele, K. J. (2012). A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. The American Journal of Gastroenterology, 107, 612–619.10.1038/ajg.2011.438
  • Buter, A., Imrie, C. W., Carter, C. R., Evans, S., & McKay, C. J. (2002). Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. British Journal of Surgery, 89, 298–302.10.1046/j.0007-1323.2001.02025.x
  • Espinosa, L., Linares, P. M., Bejerano, A., Lopez, C., Sanchez, A., Moreno-Otero, R., & Gisbert, J. P. (2011). Soluble angiogenic factors in patients with acute pancreatitis. Journal of Clinical Gastroenterology, 45, 630–637.10.1097/MCG.0b013e31820d3533
  • Hack, C. E., Hart, M., van Schijndel, R. J., Eerenberg, A. J., Nuijens, J. H., Thijs, L. G., & Aarden, L. A. (1992). Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infection and Immunity, 60, 2835–2842.
  • Halonen, K. I., Pettilä, V., Leppäniemi, A. K., Kemppainen, E. A., Puolakkainen, P. A., & Haapiainen, R. K. (2002). Multiple organ dysfunction associated with severe acute pancreatitis. Critical Care Medicine, 30, 1274–1279.10.1097/00003246-200206000-00019
  • Haydock, M. D., Mittal, A., Wilms, H. R., Phillips, A., Petrov, M. S., & Windsor, J. A. (2013). Fluid therapy in acute pancreatitis: Anybody’s guess. Annals of Surgery, 257, 182–188.10.1097/SLA.0b013e31827773ff
  • Johnson, C. D., & Abu-Hilal, M. (2004). Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut, 53, 1340–1344.10.1136/gut.2004.039883
  • Kylanpaa, L., Rakonczay, Jr., Z., & O’Reilly, D. A. (2012). The clinical course of acute pancreatitis and the inflammatory mediators that drive it. International Journal of Inflammation, 360685.
  • Lee, K. J., Kim, H. M., Choi, J. S., Kim, Y. J., Kim, Y. S., & Cho, J. H. (2016). Comparison of predictive systems in severe acute pancreatitis according to the revised Atlanta classification. Pancreas, 45, 46–50.10.1097/MPA.0000000000000433
  • Maksimow, M., Kyhälä, L., Nieminen, A., Kylänpää, L., Aalto, K., Elima, K., ... Jalkanen, S. (2014). Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis. Critical Care Medicine, 42, 2556–2564.10.1097/CCM.0000000000000550
  • Marshall, J. C., Cook, D. J., Christou, N. V., Bernard, G. R., Sprung, C. L., & Sibbald, W. J. (1995). Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome, 23. Critical Care Medicine, 1638–1652.10.1097/00003246-199510000-00007
  • Mc Kay, C. J., & Buter, A. (2003). Natural history of organ failure in acute pancreatitis. Pancreatology, 3, 111–114.10.1159/000070078
  • Mentula, P., Kylänpää, M. L., Kemppainen, E., Jansson, S. E., Sarna, S., Puolakkainen, P., ... Repo, H. (2005). Early prediction of organ failure by combined markers in patients with acute pancreatitis. British Journal of Surgery, 92, 68–75.10.1002/bjs.v92:1
  • Muddana, V., Whitcomb, D. C., Khalid, A., Slivka, A., & Papachristou, G. I. (2009). Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. The American Journal of Gastroenterology, 104, 164–170.10.1038/ajg.2008.66
  • Newcombe, R. G. (1998). Two-sided confidence intervals for the single proportion: Comparison of seven methods. Statistics in Medicine, 17, 857–872.10.1002/(ISSN)1097-0258
  • Nieminen, A., Maksimow, M., Mentula, P., Kyhälä, L., Kylänpää, L., Puolakkainen, P., … Salmi, M. (2014). Circulating cytokines in predicting development of severe acute pancreatitis. Critical Care, 18, R104.10.1186/cc13885
  • Nisula, S., Kaukonen, K. M., Vaara, S. T., Korhonen, A. M., Poukkanen, M., Karlsson, S., … Laurila, J. J. (2013). Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: The FINNAKI study. Intensive Care Medicine, 30, 420–428.10.1007/s00134-012-2796-5
  • Norman, J. (1998). The role of cytokines in the pathogenesis of acute pancreatitis. The American Journal of Surgery, 175, 76–83.10.1016/S0002-9610(97)00240-7
  • Nukarinen, E., Lindström, O., Kuuliala, K., Kylänpää, L., Pettilä, V., Puolakkainen, P., … Hästbacka, J. (2016). Association of matrix metalloproteinases -7, -8, -9 and TIMP -1 with disease severity in acute pancreatitis. PLoS One, 11(8), e0161480.10.1371/journal.pone.0161480
  • Penttila A. K., Rouhiainen A., Kylanpaa L., Mustonen, H., Puolakkainen, P., Rauvala, H., & Repo, H. (2016). Circulating nucleosomes as predictive markers of severe acute pancreatitis. Journal of Intensive Care, 4, 14. 14-016-0135-6.
  • Puolakkainen, P., Valtonen, V., Paananen, A., & Schroder, T. (1987). C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut, 28, 764–771.10.1136/gut.28.6.764
  • Rakonczay, Jr., Z., Hegyi, P., Takacs, T., McCarroll, J., & Saluja, A. K. (2008). The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut, 57, 259–267.10.1136/gut.2007.124115
  • Rau, B., Steinbach, G., Gansauge, F., Mayer, J. M., Grunert, A., & Beger, H. G. (1997). The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut, 41, 832–840.10.1136/gut.41.6.832
  • Sah, R. P., Dawra, R. K., & Saluja, A. K. (2013). New insights into the pathogenesis of pancreatitis. Current Opinion in Gastroenterology, 29, 523–530.10.1097/MOG.0b013e328363e399
  • Sporek, M., Kolber, W., Kusnierz-Cabala, B., Dumnicka, P., Gurda-Duda, A., Kuzniewski, M., … Kulig, J. (2013). Determination of hepatocyte growth factor at early phase of acute pancreatitis. Folia medica Cracoviensia, 53, 87–95.
  • Staubli, S. M., Oertli, D., & Nebiker, C. A. (2015). Laboratory markers predicting severity of acute pancreatitis. Critical Reviews in Clinical Laboratory Sciences, 52, 273–283.10.3109/10408363.2015.1051659
  • Tenner, S., Baillie, J., DeWitt, J., Vege, S. S., & American College of Gastroenterology (2013). American College of Gastroenterology guideline: Management of acute pancreatitis. The American Journal of Gastroenterology, 108, 1400–1415.10.1038/ajg.2013.218
  • Ueda, T., Takeyama, Y., Hori, Y., Nishikawa, J., Yamamoto, M., & Saitoh, Y. (1997). Hepatocyte growth factor in assessment of acute pancreatitis: Comparison with C-reactive protein and interleukin-6. Journal of Gastroenterology, 32, 63–70.10.1007/BF01213298
  • Ueda, T., Takeyama, Y., Toyokawa, A., Kishida, S., Yamamoto, M., & Saitoh, Y. (1996). Significant elevation of serum human hepatocyte growth factor levels in patients with acute pancreatitis. Pancreas, 12, 76–83.10.1097/00006676-199601000-00010
  • Vege, S. S., Gardner, T. B., Chari, S. T., Munukuti, P., Pearson, R. K., Clain, J. E., … Sarr, M. G. (2009). Low mortality and high morbidity in severe acute pancreatitis without organ failure: A case for revising the atlanta classification to include “moderately severe acute pancreatitis”. The American Journal of Gastroenterology, 104, 710–715.10.1038/ajg.2008.77
  • Windsor, J. A. (2008). Assessment of the severity of acute pancreatitis: No room for complacency. Pancreatology, 8, 105–109.10.1159/000123604
  • Windsor, J. A. (2010). A better way to predict the outcome in acute pancreatitis? The American Journal of Gastroenterology, 105, 1671–1673.10.1038/ajg.2010.145
  • Working Group IAP/APA Acute Pancreatitis Guidelines (2013). IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology, 13, e1–e15.
  • Working Party of the British Society of Gastroenterology, Association of Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain and Ireland, Association of Upper GI Surgeons of Great Britain and Ireland. (2005). UK guidelines for the management of acute pancreatitis. Gut, 54, iii1–iii9.
  • Zhang, J., Niu, J., & Yang, J. (2014). Interleukin-6, interleukin-8 and interleukin-10 in estimating the severity of acute pancreatitis: An updated meta-analysis. Hepato-Gastroenterology, 61, 215–220.